• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在假定的C末端锚定残基处被取代的肽与仅在β57位点不同的HLA - DQ8和DQ9的差异结合。

Differential binding of peptides substituted at putative C-terminal anchor residue to HLA-DQ8 and DQ9 differing only at beta 57.

作者信息

Oiso M, Nishi T, Ishikawa T, Nishimura Y, Matsushita S

机构信息

Department of Neuroscience and Immunology, Kumamoto University Graduate School of Medical Sciences, Japan.

出版信息

Hum Immunol. 1997 Jan;52(1):47-53. doi: 10.1016/s0198-8859(96)00253-4.

DOI:10.1016/s0198-8859(96)00253-4
PMID:9021409
Abstract

HLA-DQ8 (DQA10302-DQB10302: DQ beta 57 Ala) and (DQA10302-DQB10303: DQ beta 57 Asp) differ only at beta 57, at which polymorphism reportedly confers distinct susceptibility to insulin-dependent diabetes mellitus (IDDM). To identify the differential peptide binding affected by beta 57, we determined DQ9-binding peptides by affinity-based selection of a phage random peptide library using the biotinylated DQ9 complex. Nonconservative single-residue substitution of high-affinity DQ8- and DQ9-binding peptide (1KLPDYVLWSSSTVVGLGAAGA21) at the underlined residues significantly decreased the peptide binding to DQ8 and DQ9. Affinities of the wild-type 21-mer K4DYVLWSSSTV13 and K4AYAAWAAATA13 to DQ8 and DQ9 were practically the same. The K4DYVLWSSSTV13-based analogue peptides with substitutions at 12T showed that residues R, K, H, E, D, Q, N, T, S, V, L, I, F, M, W, and Y permitted binding to DQ8, whereas only R, T, V, L, I, F, M, W, and Y did so to DQ9. Thus, significant differences exist between DQ9 and DQ8, in that the majority of polar residues, regardless of their static charges at the residue 12, permitted binding to IDDM-susceptible DQ8, which is not the case for DQ9. The affinities of K4DYVLWSSSXV13 AND K4AYAAWAAAAX13 (where X is T, A, K, D, or I) were almost equal to DQ8 and DQ9, suggesting the DQ8- and DQ9-binding peptide motifs could accept both the 8-mer and 9-mer frames depending on intervening sequences between N- and C-terminal anchor residues. The biochemical basis of peptide-HLA interactions determined by DQ beta 57 is discussed.

摘要

HLA-DQ8(DQA10302-DQB10302:DQβ57位为丙氨酸)和(DQA10302-DQB10303:DQβ57位为天冬氨酸)仅在β57位不同,据报道该多态性赋予了对胰岛素依赖型糖尿病(IDDM)不同的易感性。为了确定受β57影响的差异肽结合情况,我们通过使用生物素化的DQ9复合物基于亲和力筛选噬菌体随机肽库来确定DQ9结合肽。对高亲和力的DQ8和DQ9结合肽(1KLPDYVLWSSSTVVGLGAAGA21)下划线处的残基进行非保守单残基替换,显著降低了该肽与DQ8和DQ9的结合。野生型21肽K4DYVLWSSSTV13和K4AYAAWAAATA13与DQ8和DQ9的亲和力实际上是相同的。以K4DYVLWSSSTV13为基础在12T处进行替换的类似肽表明,残基R、K、H、E、D、Q、N、T、S、V、L、I、F、M、W和Y允许与DQ8结合,而只有R、T、V、L、I、F、M、W和Y允许与DQ9结合。因此,DQ9和DQ8之间存在显著差异,即大多数极性残基,无论其在12位的静电荷如何,都允许与IDDM易感的DQ8结合,而DQ9则不然。K4DYVLWSSSXV13和K4AYAAWAAAAX13(其中X为T、A、K、D或I)与DQ8和DQ9的亲和力几乎相等,表明DQ8和DQ9结合肽基序可根据N端和C端锚定残基之间的间隔序列接受8肽和9肽框架。本文讨论了由DQβ57决定的肽与HLA相互作用的生化基础。

相似文献

1
Differential binding of peptides substituted at putative C-terminal anchor residue to HLA-DQ8 and DQ9 differing only at beta 57.在假定的C末端锚定残基处被取代的肽与仅在β57位点不同的HLA - DQ8和DQ9的差异结合。
Hum Immunol. 1997 Jan;52(1):47-53. doi: 10.1016/s0198-8859(96)00253-4.
2
Evidence that HLA-DQ9 confers risk to celiac disease by presence of DQ9-restricted gluten-specific T cells.存在 DQ9 限制性麸质特异性 T 细胞表明 HLA-DQ9 通过存在赋予乳糜泻风险。
Hum Immunol. 2012 Apr;73(4):376-81. doi: 10.1016/j.humimm.2012.01.016. Epub 2012 Jan 31.
3
HLA-DQ-binding peptide motifs. 1. Comparative binding analysis of type II collagen-derived peptides to DR and DQ molecules of rheumatoid arthritis-susceptible and non-susceptible haplotypes.HLA-DQ结合肽基序。1. 类风湿关节炎易感和非易感单倍型的II型胶原衍生肽与DR和DQ分子的比较结合分析。
Int Immunol. 1996 May;8(5):757-64. doi: 10.1093/intimm/8.5.757.
4
Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes.与两种疾病特异性表位复合的乳糜泻相关HLA - DQ8和非相关HLA - DQ9等位基因的结构
Int Immunol. 2000 Aug;12(8):1157-66. doi: 10.1093/intimm/12.8.1157.
5
Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2).利用洗脱肽序列数据鉴定肽与胰岛素依赖型糖尿病易感等位基因HLA - DQ8(DQ 3.2)的结合特性。
Int Immunol. 1997 Jun;9(6):905-11. doi: 10.1093/intimm/9.6.905.
6
Biochemical characterization of the human diabetes-associated HLA-DQ8 allelic product: similarity to the major histocompatibility complex class II I-A(g)7 protein of non-obese diabetic mice.人类糖尿病相关HLA-DQ8等位基因产物的生化特性:与非肥胖糖尿病小鼠的主要组织相容性复合体II类I-A(g)7蛋白相似。
Eur J Immunol. 1997 Oct;27(10):2478-83. doi: 10.1002/eji.1830271003.
7
Critical residues on HLA-DRB1*0402 HV3 peptide for HLA-DQ8-restricted immunogenicity: implications for rheumatoid arthritis predisposition.HLA-DRB1*0402高变区3肽上对HLA-DQ8限制的免疫原性起关键作用的残基:对类风湿性关节炎易感性的影响
J Immunol. 1997 Apr 1;158(7):3545-51.
8
Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice.使用人CD4、DQA1*0301、DQB1*0302转基因IA(无)NOD小鼠定位人GAD65的主要DQ8限制性T细胞表位。
Diabetes. 1999 Mar;48(3):469-77. doi: 10.2337/diabetes.48.3.469.
9
Association of HLA-DR, DQ genotype with different beta-cell functions at IDDM diagnosis in Japanese children.日本儿童1型糖尿病诊断时HLA - DR、DQ基因型与不同β细胞功能的关联
Diabetes. 1997 Nov;46(11):1893-7. doi: 10.2337/diab.46.11.1893.
10
Differences in self-peptide binding between T1D-related susceptible and protective DR4 subtypes.1 型糖尿病相关易感和保护性 DR4 亚型之间自身肽结合的差异。
J Autoimmun. 2011 Mar;36(2):155-60. doi: 10.1016/j.jaut.2010.12.004. Epub 2011 Jan 22.

引用本文的文献

1
Cell-surface MHC density profiling reveals instability of autoimmunity-associated HLA.细胞表面MHC密度分析揭示了自身免疫相关HLA的不稳定性。
J Clin Invest. 2015 Jan;125(1):275-91. doi: 10.1172/JCI74961. Epub 2014 Dec 8.
2
Natural peptides selected by diabetogenic DQ8 and murine I-A(g7) molecules show common sequence specificity.由致糖尿病的DQ8和小鼠I-A(g7)分子选择的天然肽显示出共同的序列特异性。
J Clin Invest. 2005 Aug;115(8):2268-76. doi: 10.1172/JCI25350.